EGLN3 and hereditary elliptocytosis: EGLN3 (egl-9 family hypoxia-inducible factor 3) was validated as a novel ammonia resistance gene in this study and it is a potential therapeutic target for ameliorating ammonia induced neurotoxicity in HE.